1. Home
  2. GOSS vs HOV Comparison

GOSS vs HOV Comparison

Compare GOSS & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.57

Market Cap

726.8M

Sector

Health Care

ML Signal

HOLD

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

HOLD

Current Price

$101.60

Market Cap

591.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
HOV
Founded
2015
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
726.8M
591.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
GOSS
HOV
Price
$3.57
$101.60
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$8.60
$120.00
AVG Volume (30 Days)
3.3M
128.4K
Earning Date
11-05-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
7.43
Revenue
$44,051,000.00
$2,978,581,000.00
Revenue This Year
N/A
$7.30
Revenue Next Year
$6.41
$4.88
P/E Ratio
N/A
$14.27
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$81.15
52 Week High
$3.87
$162.06

Technical Indicators

Market Signals
Indicator
GOSS
HOV
Relative Strength Index (RSI) 56.81 38.93
Support Level $3.53 $104.84
Resistance Level $3.87 $110.17
Average True Range (ATR) 0.24 6.41
MACD -0.02 -0.33
Stochastic Oscillator 51.96 17.43

Price Performance

Historical Comparison
GOSS
HOV

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.

Share on Social Networks: